Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.8490
+0.0400 (4.94%)
Oct 8, 2025, 12:30 PM EDT - Market open
Longeveron Market Cap
Longeveron has a market cap or net worth of $17.88 million as of October 8, 2025. Its market cap has decreased by -38.96% in one year.
Market Cap
17.88M
Enterprise Value
7.84M
1-Year Change
-38.96%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $17.88M, a decrease of -89.63%. That is a compound annual growth rate of -38.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 17.04M | -33.62% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | 172.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |